SEC Tracker
Get the app

Liang Howard

Bambusa Therapeutics, Inc. reports Howard Liang's ownership

Howard Liang, new insider at Bambusa Therapeutics, Inc.

Form
3
Filed
Importance
Routine
  1. Liang Howard is a director and 10% owner
  2. Owns 153,908 shares via stock option
  3. Stock option vests monthly starting July 1, 2026
  4. Exercise price is $8.04 per share

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Liang Howard files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.